Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
In 2026, 13 top biopharma firms adopted Veeva Link Key People for AI-driven customer engagement, boosting data accuracy and patient outcomes.
In 2026, 13 of the world’s top 20 biopharmaceutical companies adopted Veeva Link Key People as their global standard for customer engagement and AI initiatives.
The platform provides structured data on healthcare professionals, integrated with Veeva’s Data Cloud and Common Data Architecture, enabling better decision-making across medical, commercial, and analytics teams.
Recent upgrades include AI-powered summaries, personalized alerts, and a new data API.
Companies like Bayer AG are embedding the tool into their core data systems to improve AI accuracy and patient-focused outcomes.
Adoption continues to grow, with 38 new customers in the past year, including several top-tier firms, reflecting a shift toward data-driven innovation in the life sciences industry.
En 2026, 13 de las principales firmas biofarmacéuticas adoptaron Veeva Link Key People para el compromiso de los clientes impulsado por la IA, aumentando la precisión de los datos y los resultados para los pacientes.